UBS Lux Equity Fund Biotech USD vs Evli High Yield

UBS Lux Equity Fund Biotech USD vs Evli High Yield

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Evli High Yield

  • Security

    Evli High Yield B

  • Fee

    1.11%

  • ISIN

    FI0008803929

  • Holdings

    16

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Evli High Yield, we have 16 holdings where Iliad Holding is the largest holding (1.33), followed by BMW (1.31) and Lorca Telecom Bondco (1.3).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Evli High Yield.

UBS Lux Equity Fund Biotech USD Evli High Yield
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Iliad Holding SAS
France
1.33 %
2. Moderna Inc
9.21 %
2. Bayerische Motoren Werke AG
Germany
1.31 %
3. Gilead Sciences Inc
USA
4.66 %
3. Lorca Telecom Bondco SAU
Spain
1.3 %
4. BioNTech SE
4.13 %
4. BPCE SA
France
1.21 %
5. Karuna Therapeutics Inc
3.75 %
5. Allianz SE
Germany
1.16 %
- 6. Commerzbank AG
Germany
1.09 %
- 7. Credit Agricole SA
France
1.01 %
- 8. Nidda Healthcare Holding GmbH
Germany
1.01 %
- 9. Zegona Finance Plc
UK
1 %
- 10. Telefónica Europe BV
Netherlands
0.99 %
- 11. UPCB Finance VII Ltd
Cayman Islands
0.97 %
- 12. Dynamo Newco II GmbH
Germany
0.93 %
- 13. NTI Group Holding ApS
Denmark
0.92 %
- 14. Boels Topholding NV
Netherlands
0.91 %
- 15. CaixaBank SA
Spain
0.89 %
- 16. Eroski Sociedad Cooperativa
Spain
0.88 %

The list of fund holdings was last updated on September 10, 2025.